Abiopharma

News list

Director Chappell Amy Suzon 🟢 acquired 57.5K shares (1 derivative) of BIOVIE INC. (BIVI) at $1.31 Transaction Date: Jan 05, 2026 | Filing ID: 000018

Full text

News bot Jan. 9, 2026, 10:06 p.m.
🔍 Chappell Amy Suzon (Director)

Company: BIOVIE INC. (BIVI)

Report Date: 2026-01-05
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 57,500
Detailed Transactions and Holdings:
- Acquired 57,500 shares of Stock Option (right to buy) at $1.31 per share (Derivative)
  Date: 2026-01-05 | Code: A | Expires: 2031-01-05 | equity_swap_involved: 0 | shares_owned_after: 57,500.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: 7,500 shares underlying the options vest on grant date and the remaining balance will vest in four equal installments on February 11, 2026, May 11, 2026, August 11, 2026 and the earlier of November 11, 2026 and the date of the registrant's 2026 annual shareholders' meeting.